David Wiseman

439 total citations
23 papers, 352 citations indexed

About

David Wiseman is a scholar working on Molecular Biology, Pollution and Pharmacology. According to data from OpenAlex, David Wiseman has authored 23 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Pollution and 4 papers in Pharmacology. Recurrent topics in David Wiseman's work include Pharmaceutical and Antibiotic Environmental Impacts (7 papers), Antibiotic Resistance in Bacteria (4 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). David Wiseman is often cited by papers focused on Pharmaceutical and Antibiotic Environmental Impacts (7 papers), Antibiotic Resistance in Bacteria (4 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). David Wiseman collaborates with scholars based in United Kingdom, United States and Canada. David Wiseman's co-authors include Murray S. Webb, B. Brett Finlay, Michael J. Hope, Peter Lutwyche, Maryse St‐Louis, Nancy L. Boman, Kim F. Wong and Jennifer Evans and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Clinical Pathology and Journal of Pharmacy and Pharmacology.

In The Last Decade

David Wiseman

23 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Wiseman United Kingdom	8	143	67	65	55	49	23	352
Christian Beaulac Canada	8	182 1.3×	44 0.7×	120 1.8×	88 1.6×	30 0.6×	9	480
Henry Devlin Ireland	11	212 1.5×	19 0.3×	23 0.4×	88 1.6×	55 1.1×	11	512
C. Finance France	13	155 1.1×	16 0.2×	30 0.5×	17 0.3×	104 2.1×	27	409
Bárbara Cedré Cuba	12	78 0.5×	38 0.6×	50 0.8×	17 0.3×	19 0.4×	36	487
Santhni Subramaniam Australia	10	128 0.9×	60 0.9×	68 1.0×	27 0.5×	24 0.5×	16	330
Luyan Zhu China	11	160 1.1×	54 0.8×	273 4.2×	15 0.3×	25 0.5×	13	482
Ainhoa Lucía Spain	11	94 0.7×	58 0.9×	75 1.2×	30 0.5×	42 0.9×	23	351
Alhanouf I. Al-Harbi Saudi Arabia	11	171 1.2×	46 0.7×	67 1.0×	63 1.1×	21 0.4×	21	540
Kathleen Dillen Belgium	5	109 0.8×	180 2.7×	300 4.6×	18 0.3×	67 1.4×	7	507

Countries citing papers authored by David Wiseman

Since Specialization

Citations

This map shows the geographic impact of David Wiseman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Wiseman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Wiseman more than expected).

Fields of papers citing papers by David Wiseman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Wiseman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Wiseman. The network helps show where David Wiseman may publish in the future.

Co-authorship network of co-authors of David Wiseman

This figure shows the co-authorship network connecting the top 25 collaborators of David Wiseman. A scholar is included among the top collaborators of David Wiseman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Wiseman. David Wiseman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wiseman, David, et al.. (2000). Antibacterial Efficacy of Gentamicin Encapsulated in pH-Sensitive Liposomes against an In Vivo Salmonella enterica Serovar Typhimurium Intracellular Infection Model. Antimicrobial Agents and Chemotherapy. 44(3). 533–539. 59 indexed citations

Lutwyche, Peter, David Wiseman, Maryse St‐Louis, et al.. (1998). Intracellular Delivery and Antibacterial Activity of Gentamicin Encapsulated in pH-Sensitive Liposomes. Antimicrobial Agents and Chemotherapy. 42(10). 2511–2520. 99 indexed citations

Webb, Murray S., et al.. (1998). Antibacterial Efficacy against an In Vivo Salmonella typhimurium Infection Model and Pharmacokinetics of a Liposomal Ciprofloxacin Formulation. Antimicrobial Agents and Chemotherapy. 42(1). 45–52. 69 indexed citations

Wiseman, David, et al.. (1981). Testing of Some Antimalarial Drugs for Mutagenic Activity. Journal of Pharmacy and Pharmacology. 33(Supplement_1). 75P–75P. 1 indexed citations

Wiseman, David, et al.. (1981). The Uptake of Nonyl and Tetradecyl Benzyldimethylammonium Compounds by Escherichia Coli. Journal of Pharmacy and Pharmacology. 33(Supplement_1). 30P–30P. 1 indexed citations

Wiseman, David, et al.. (1979). The Effect of Chloroquine on Macromolecule Synthesis and Oxygen Uptake in Escherichia Coli. Journal of Pharmacy and Pharmacology. 31(Supplement_1). 31P–31P. 1 indexed citations

Wiseman, David, et al.. (1979). Measurement of formaldehyde concentrations in a subatmospheric steam-formaldehyde autoclave.. Journal of Clinical Pathology. 32(6). 567–575. 6 indexed citations

Wiseman, David, et al.. (1974). The effect of chloroquine on the growth and viability of Escherichia coli. Journal of Pharmacy and Pharmacology. 26(Supplement_1). 99P–100P. 4 indexed citations

Wiseman, David. (1971). The effect of cetyltrimethylammonium bromide on the cytochrome system ofEscherichia coli. Journal of Pharmacy and Pharmacology. 23(Supplement_1). 257S–258S. 2 indexed citations

10.

Wiseman, David. (1970). Oxygen therapy in cardiopulmonary disease.. PubMed. 102(6). 989–90. 1 indexed citations

11.

Wiseman, David, et al.. (1970). The effect of magnesium ions and Tris buffer on the uptake of cetyl trimethyl ammonium bromide by Escherichia coli. Journal of Pharmacy and Pharmacology. 22(10). 767–773. 6 indexed citations

12.

Wiseman, David, et al.. (1970). The relation between the uptake of cetyltri-methylammonium bromide by Escherichia coli and its effects on cell/growth and viability. Journal of Pharmacy and Pharmacology. 22(4). 261–264. 19 indexed citations

13.

Wiseman, David, et al.. (1968). The partially inhibited growth of Escherichia coli in the presence of some antibacterial agents. Journal of Pharmacy and Pharmacology. 20(9). 697–703. 3 indexed citations

14.

Wiseman, David, et al.. (1968). Cell size changes during the growth of Escherichia coli partially inhibited by some antibacterial agents. Journal of Pharmacy and Pharmacology. 20(Supplement_1). 8S–13S. 1 indexed citations

15.

Wiseman, David, et al.. (1967). Some factors affecting the sizing and counting of Escherichia coli with the Coulter Counter.. PubMed. 19. Suppl:9S–14S. 4 indexed citations

16.

Wiseman, David, et al.. (1966). Effect of chlorhexidine upon 32P release and cell viability in Escherichia coli. Journal of Pharmacy and Pharmacology. 18(Supplement_1). 114S–118S. 11 indexed citations

17.

Wiseman, David, et al.. (1965). Chemical fractionation of phosphorus-32 labelled cells of Micrococcus lysodeikticus treated with chlorhexidine. Journal of Pharmacy and Pharmacology. 17(5). 295–301. 9 indexed citations

18.

Wiseman, David. (1964). THE EFFECT OF CHLORHEXIDINE ON THE PERMEABILITY AND SUCCINOXIDASE ACTIVITY OF MICROCOCCUS LYSODEIKTICUS.. PubMed. 16. SUPPL:56–7T. 3 indexed citations

19.

Wiseman, David, et al.. (1964). Release of phosphorus-32-containing compounds from Micrococcus lysodeikticus treated with chlorhexidine. Journal of Pharmacy and Pharmacology. 16(8). 516–521. 31 indexed citations

20.

Wiseman, David. (1963). A Common Antigen in the Cell Walls of Three Lysozyme-Sensitive Bacteria. Journal of Pharmacy and Pharmacology. 15(Supplement_1). 182T–184T. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact